Lipella pharmaceuticals co-founder michael chancellor featured on the pharmaverse podcast

Pittsburgh, march 31, 2025 (globe newswire) -- lipella pharmaceuticals inc. (nasdaq: lipo) (“lipella,” “our,” “us,” or the “company”), a clinical-stage biotechnology company addressing serious diseases with significant unmet needs, today announced that co-founder and chief medical officer dr. michael chancellor is featured in the latest episode of the pharmaverse podcast, hosted by pharmaceutical industry executive recruiter michael pietrack. the episode, titled “from medicine to biotech innovation,” offers an inside look at dr. chancellor's journey from clinical medicine to biotech leadership.
LIPO Ratings Summary
LIPO Quant Ranking